Hemostats Market Trends

Growth Drivers

Rise in the Number of Hospitals and Clinics- The hospitals and clinics are rising at a remarkable pace owing to their reinforced coverage, services, and additional expenditure by the public as well as private investors. There are nearly 11,000 hospitals in China, around 2000 in the United Kingdom, and approximately 6000 hospitals in the United States
Higher Instances of Accidents- According to the World Health Organization, every year nearly 1.3 million people die due to road accidents and road accidents are the primary cause of death among people of age between 5 to 29 years
Increasing Requirement for Blood Transfusion- The global burden of blood transfusion is reported around 76% among adults of age 60 and above and nearly 54% in children by the World Health Organization.
Rise in the Number of People Suffering from Cancer- As per the data of the World Health Organization, in 2020, there were nearly 10 million deaths as a result of cancer. Moreover, there were around 2.26 million new cases of breast cancer and over 2 million of lung cancer.

Challenges

Higher Cost of the Product - Clinical procedures require different types of hemostats for different operations, the cost of these products is a little higher, therefore, which imposes restrictions on clinics to have every kind of hemostat, moreover it also hinders the growth of the market. Compared to other adjunctive hemostats (OAHs), the average cost of a topical adjunctive hemostat was 47% lower using ORCs (oxidized regenerated celluloses), or a savings of USD 88 per treatment.
Cases of Unlimited Bleeding to Limit the Demand for the Hemostats
Shortage of Trained Expertise and Skilled Professionals

Hemostats Market: Key Insights

Base Year	2022
Forecast Year	2023-2033
CAGR	~6%
Base Year Market Size (2022)	~ USD 2900 Million
Forecast Year Market Size (2033)	~ USD 5000 Million
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year	2024
Forecast Year	2025-2037
CAGR	6.4%
Base Year Market Size (2024)	USD 3.28 billion
Forecast Year Market Size (2037)	USD 7.26 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hemostats is assessed at USD 3.45 billion.

The hemostats market size was valued at USD 3.28 billion in 2024 and is set to reach USD 7.26 billion by the end of 2037, registering around 6.4% CAGR during the forecast period i.e., between 2025-2037. Rising need of blood transfusion, increased cases of cancer, increase in number of hospitals and higher chances of road accidents will boost the market growth.

North America is expected to hold majority industry share by 2037, owing to region's early adoption of a variety of technologically cutting-edge medical products and solutions as well as rise in demand for dependable hemostat solutions.

The major players in the market include Pfizer Inc., Integra LifeSciences Corporation, Baxter, Medtronic, Stryker, BD (Becton, Dickinson and Company), Biom'up Innovative Surgery, Johnson & Johnson Services, Inc., CryoLife, Inc., Hemostatis LLC.

Hemostats Market Trends